ENVX.NASDAQEnovix CORP

Form 4: Enovix Director Gregory Reichow Granted Over 22,000 Restricted Stock Units

Sentiment:

Insider Transaction Report


Enovix Corp Director Gregory Reichow was granted 22,543 restricted stock units, vesting over approximately one year, as part of his compensation.

Summary

  • Enovix Corp Director Gregory Reichow was granted 22,543 shares of common stock in the form of Restricted Stock Units (RSUs).
  • The transaction date for this grant was June 12, 2025.
  • These RSUs will vest in four equal installments of 25% on September 12, 2025, December 12, 2025, March 12, 2026, and the earlier of June 12, 2026, or the date of the Issuer's 2026 annual meeting of stockholders, subject to continuous service.
  • Following this transaction, Mr. Reichow beneficially owns 58,281 shares, which includes the newly granted RSUs and 26,325 shares from previously granted RSUs.
  • The RSUs are deemed to be held for the benefit of Eclipse Ventures, LLC, with Mr. Reichow disclaiming beneficial ownership except to the extent of any pecuniary interest therein.

Sentiment

Score: 7

Explanation: The grant of RSUs to a director is generally a positive signal, indicating alignment of interests and retention of key personnel, despite the inherent dilution from equity compensation.

Positives

  • The grant of Restricted Stock Units (RSUs) to a director aligns management's interests with long-term shareholder value, as vesting is contingent on continued service.
  • An increase in beneficial ownership by a director can signal confidence in the company's future prospects.

Negatives

  • The transaction involves a grant of shares at $0 price, which, upon vesting and issuance, will result in dilution to existing shareholder value, although this is a standard form of executive compensation.

Risks

  • The vesting of RSUs is subject to the Reporting Person's continuous service, meaning the shares are not guaranteed if service ceases before the applicable vesting dates.
  • The beneficial ownership arrangement with Eclipse Ventures, LLC, introduces complexity regarding direct control and pecuniary interest, as the Reporting Person disclaims beneficial ownership except for pecuniary interest.

Future Outlook

The document outlines a future vesting schedule for Restricted Stock Units granted to Director Gregory Reichow, with shares expected to vest quarterly from September 2025 through June 2026, contingent on his continuous service to the company.

Industry Context

This Form 4 filing reflects a standard practice of executive and director compensation within the technology and manufacturing sectors, where equity grants like Restricted Stock Units are commonly used to incentivize long-term commitment and align interests with shareholders.

Related Party Transactions

  • The 22,543 RSUs, and 26,325 previously granted RSUs, are deemed to be held for the benefit of Eclipse Ventures, LLC. Gregory Reichow, as a partner of Eclipse, may share voting and dispositive power over shares held by Eclipse, indicating a related party transaction where the shares upon settlement will be held by an entity with which the director has an affiliation.

Stakeholder Impact

  • Shareholders: Potential minor dilution from the issuance of new shares upon RSU vesting, but also benefit from increased alignment of director interests with long-term company performance and retention.
  • Employees: No direct impact mentioned.
  • Customers: No direct impact mentioned.
  • Suppliers: No direct impact mentioned.
  • Creditors: No direct impact mentioned.

Next Steps

  • Continued service of Gregory Reichow as a director of Enovix Corp to ensure vesting of RSUs.
  • Vesting of 25% of the granted RSUs on September 12, 2025.
  • Vesting of 25% of the granted RSUs on December 12, 2025.
  • Vesting of 25% of the granted RSUs on March 12, 2026.
  • Final vesting of 25% of the granted RSUs on June 12, 2026, or earlier based on the 2026 annual meeting of stockholders.

Key Dates

DateDescription
06/12/2025Date of earliest transaction (grant of Restricted Stock Units).
06/13/2025Signature date of the SEC Form 4 filing.
09/12/2025First 25% vesting date for the 22,543 granted RSUs.
12/12/2025Second 25% vesting date for the 22,543 granted RSUs.
03/12/2026Third 25% vesting date for the 22,543 granted RSUs.
06/12/2026Fourth and final 25% vesting date for the 22,543 granted RSUs, or earlier if tied to the 2026 annual meeting of stockholders.

Recommendation

hold

Keywords

Enovix Corp, ENVX, SEC Form 4, Restricted Stock Units, RSUs, Director Compensation, Insider Transaction, Stock Grant, Beneficial Ownership, Gregory Reichow, Eclipse Ventures

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.